iPS-NKT cell therapy (Japan Agency for Medical Research and Development)

N/A

Report date: 2025/06/11 10:52:51

Base Information

Drug NameiPS-NKT cell therapy (Japan Agency for Medical Research and Development)
Drug Alias Nameinduced pluripotent stem cell natural killer T cell therapy (Japan Agency for Medical Research and Development)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunostimulantsNatural killer T-lymphocyte stimulants
TargetsNot applicable
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJapan Agency For Medical Research And Development
China Registration ClassN/A

Develop Information

Active CompaniesJapan Agency For Medical Research And Development
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A